Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Neurodevelopmental Outcomes at Five Years After Early-Onset Fetal Growth Restriction

Analyses in a Dutch Subgroup Participating in a European Management Trial

Pels, A.; Knaven, O. C.; Wijnberg-Williams, B. J.; Eijsermans, M. J. C.; Mulder-de Tollenaer, S. M.; Aarnoudse-Moens, C. S. H.; Koopman-Esseboom, C.; van Eyck, J.; Derks, J. B.; Ganzevoort, W.; van Wassenaer-Leemhuis, A. G.

Obstetrical & Gynecological Survey: August 2019 - Volume 74 - Issue 8 - p 462–464
doi: 10.1097/01.ogx.0000578692.65024.12

(Abstracted from Eur J Obstet Gynecol Reprod Biol 2019;234:63–70)

Uteroplacental insufficiency is the most common cause of fetal growth restriction (FGR), with potentially critical consequences for both the mother and fetus. Definitions of uteroplacental insufficiency vary between an antenatal diagnosis reflecting the placental dysfunction and a postnatal diagnosis based on birth weight.

Department of Obstetrics and Gynecology, Amsterdam UMC, University of Amsterdam, Amsterdam (A.P., O.C.K., W.G.); Department of Pediatrics, Isala Hospital, Zwolle (B.J.W.-W., S.M.M.-T.); Child Development & Exercise Center (M.J.C.E., C.K.-E.) and Department of Obstetrics, Gynecology and Neonatalogy (J.B.D.), Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht; Department of Pediatrics, Amsterdam UMC, University of Amsterdam, Amsterdam (C.S.H.A.-M., A.G.v.W.-L.); and Department of Obstetrics and Gynecology, Isala Hospital, Zwolle (J.v.E.), the Netherlands

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.